olanzapine-ly170053

Description: Olanzapine (formerly LY-170052, LY 170052, Zyprexa, Zolafren), a thienobenzodiazepine analog, is an approved and atypical antipsychotic drug with high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist. It is a dopamine antagonist and is classified as a thienobenzodiazepine. Binding studies showed that olanzapine interacted with keyreceptorsof interest in schizophrenia, exihibiting a nanomolar affinity for dopaminergic, serotonergic, alpha 1-adrenergic, and muscarinic receptors. It is approved by the U.S. FDA for the treatment of schizophrenia and bipolar disorder. Olanzapine is structurally similar to clozapine and quetiapine.

References: J Clin Psychiatry. 1997; 58 Suppl 10:28-36; Neuropsychopharmacology. 2000 Sep; 23(3):250-62.

Related CAS#: 174794-02-6 (Olanzapine N-Oxide)